Detalhe da pesquisa
1.
A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer.
J Urol
; 188(6): 2391-7, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23088985
2.
Phase 1 study of escalating-dose OncoGel (ReGel/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions.
Anticancer Drugs
; 18(3): 283-9, 2007 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-17264760